Hyaluronic acid holds water. Some nasal studies suggest less blockage and runniness, but the results vary a lot.
Promising nasal evidence; substantial variation
What the study actually found
Systematic review and meta-analysis of 11 trials. 825 participants with varied nasal inflammatory conditions, without surgery.
Pooled obstruction and runny-nose scores improved. Quality of life, smell, itching and sneezing did not show clear pooled advantages.
The limit: Different illnesses, formulations and other treatments make a universal product recommendation unreliable. A correction adds a possibly spray-related headache report.
Systematic review of four studies. 302 people with idiopathic nonallergic rhinitis.
Small studies reported improvement in overall nasal symptoms. Evidence quality was low to moderate; results could not be pooled.
The limit: This is a physician-supervised option for a specific diagnosis. It can burn and cause sneezing or coughing; adverse-effect reporting was inadequate. Do not improvise with chili or pepper.
NAC can loosen the bonds that make mucus sticky. Researchers tested it in rinses during recovery from surgery.
Early postoperative evidence
What the study actually found
Preliminary single-blind randomized trial. Patients with chronic rhinosinusitis without polyps after endoscopic sinus surgery.
The study reported early postoperative advantages for post-nasal drip, smell dysfunction and crusting compared with saline.
The limit: A small postoperative trial cannot establish routine benefit for an undiagnosed blocked nose, or for an oral NAC supplement. Formulation and supervision matter.
The idea is to trap some virus particles in a coating. A plausible mechanism does not guarantee a shorter or easier cold.
Mixed findings; primary endpoint not met
What the study actually found
Double-blind randomized placebo-controlled trial. 200 adults with early common-cold symptoms.
The primary symptom comparison was not statistically significant. Some exploratory analyses after unblinding favored carrageenan; average cold duration was similar.
The limit: Mixed clinical evidence. This trial does not establish allergy or chronic-sinusitis treatment, nor broad protection against respiratory infection.
Researchers are asking whether changing gut microbes can change allergy symptoms in the nose. Strains are not interchangeable.
Possible small benefit; strain uncertainty
What the study actually found
Systematic review and meta-analysis of randomized trials. People with allergic rhinitis receiving different probiotic formulations.
The review found small improvements in some clinical and immune measures.
The limit: Inconsistent outcomes and too few trials for each strain prevent a dependable best-product choice. Oral research does not justify putting probiotic capsules into a rinse.
A specific herbal extract for acute viral rhinosinusitis
One standardized mixture of five plants was tested as an oral medicine. It helped symptoms more than placebo in these trials.
Human evidence for this exact extract
What the study actually found
Pooled analysis of two randomized placebo-controlled trials. 589 patients with acute viral rhinosinusitis.
The BNO 1016 group had a statistically lower combined symptom score at the end of treatment.
The limit: Evidence belongs to this extract and acute illness. It does not establish that every Sinupret formulation, herbal tea or similar supplement works for chronic sinus disease.
Zinc may shorten a cold, but the estimate is uncertain and unpleasant side effects are more common.
Uncertain cold benefit; route matters
What the study actually found
Systematic review. Trials of zinc for cold prevention and treatment.
The treatment-duration analysis suggested roughly two fewer days of illness, with low confidence in the evidence. Prevention showed little or no clear benefit.
The limit: Forms and study results varied. Nasal zinc has a separate risk of lasting smell loss and should not be used; oral products also need an interaction and safety check.
Acupuncture has some supportive studies. Butterbur has possible benefits but important safety problems. “Natural” does not settle either question.
Benefits and cautions vary by approach
What the study actually found
Research overview linking clinical trials and systematic reviews. Studies of allergic rhinitis.
Acupuncture trials suggest symptom and quality-of-life improvements. Butterbur findings are less convincing and some trials have manufacturer funding.
The limit: Butterbur can contain liver-toxic pyrrolizidine alkaloids; even PA-free products need caution. Acupuncture requires a qualified practitioner and sterile needles.
Acemannan is an aloe-derived polysaccharide studied as a repair material. Results from teeth, bone or skin do not tell us whether putting it in the nose helps nasal symptoms.
Nasal benefit not established by this review
What the study actually found
Narrative review of laboratory, animal and clinical research. Primarily tissue regeneration, dental applications and wound repair.
The review discusses tissue scaffolds, gels and related biomaterials. Its sinus-augmentation studies concern bone formation for dental implants.
The limit: This is not a nasal-rinse trial. It does not establish a nasal dose, safety for nasal cilia or benefit for rhinitis, congestion or sinusitis. Do not add aloe gel or supplement powder to a rinse.
Some small studies looked encouraging. Looking more closely, it is still unclear whether adding xylitol helps more than saline alone.
Routine added benefit unproven
What the study actually found
Critical appraisal of clinical studies. Adults with chronic rhinosinusitis, including after surgery.
The appraisal found no robust evidence for routinely adding xylitol. A 70-person postoperative trial did not show a clear between-group advantage for endoscopy or smell outcomes.
The limit: This is a critical review, not a new trial. It does not prove that nobody benefits. Small studies, bias and different statistical approaches complicate the result.
A cooling smell can make breathing feel easier even when the measured air passage has not changed.
Sensory effect; not a rinse trial
What the study actually found
Experimental vapour exposure study. People exposed to camphor, eucalyptus or menthol vapour.
Participants often reported cooling or improved airflow sensation, without a measured change in nasal airway resistance.
The limit: This was vapour exposure, not a nasal rinse trial. It cannot establish that a commercial eucalyptus or Alkalol pod works better than plain saline.
For some long-lasting sinus problems, doctors use a larger wash to help keep the passages clear.
Guideline-supported use
What the study actually found
Clinical practice guideline. Adults with chronic rhinosinusitis or sinus surgery.
Recommends saline irrigation and favors high-volume delivery for this population. It lists postoperative xylitol as an option; newer evidence appraisal is more cautious.
The limit: Guidance for diagnosed chronic disease. It does not establish Naväge superiority. For water safety, use current CDC guidance and the device label.
Researchers compared many nose medicines. Sprays that calm inflammation helped; some combination sprays helped more.
Broad evidence, varying certainty
What the study actually found
Network meta-analysis · 167 primary studies. Adults with seasonal or perennial allergic rhinitis.
Intranasal steroid–antihistamine combinations ranked highest across assessed outcomes, usually followed by nasal steroids.
The limit: Many comparisons are indirect; certainty varies. A fixed combination trial does not mean you should combine products yourself. Original Flonase and Sensimist contain different molecules.
Some medicines briefly make the swollen space smaller. That does not make the cold go away.
Small / uncertain clinical benefit
What the study actually found
Systematic review · 15 trials. Mostly adults with the common cold.
Repeated doses had a small average benefit for perceived congestion; its practical importance was uncertain.
The limit: Oral and topical medicines were studied. Single-dose evidence was insufficient. Short trials cannot remove the rebound risk of overusing sprays.